Skip to content

Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens

An Open Label, Non-comparative Study to Assess the Visual Performances and Safety of a Progressive Multifocal Intraocular Lens With Extended Depth of Focus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02838004
Acronym
PSM15
Enrollment
77
Registered
2016-07-20
Start date
2016-08-31
Completion date
2017-10-31
Last updated
2020-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract, Presbyopia

Keywords

Refractive lens exchange (RLE) or cataract surgery

Brief summary

This is an interventional, non-controlled, multicenter international trial with a prospective design on one cohort of patients.

Detailed description

To evaluate if the positive results (to assure a good visual acuity at all distances and a good quality of life in terms of glasses independence and absence of undesired events), obtained experimentally using the IOL MINI WELL READY, can be confirmed in the practical surgical routine with a population belonging to different EU countries

Interventions

DEVICEIOL MINI WELL READY

IOL MINI WELL READY

Sponsors

Opera CRO, a TIGERMED Group Company
CollaboratorOTHER
SIFI SpA
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any gender and age above 18 years. * Refractive lens exchange (RLE) or cataract surgery. * Healthy corneas, not treated surgically. * Patients willing to have surgery in both eyes in a short period of time (within 2 weeks). * Patients request to receive the IOL MINI WELL READY implant

Exclusion criteria

* Previous corneal surgery (i.e. pterygium, refractive surgery). * Eye diseases determining a probable postoperative visual acuity \< 20/40. * Pseudoexfoliation. * Abnormal pupil size and position. * Use of contact lens 30 days before the preoperative visit. * Corneal warpage. * Predicted postoperative corneal astigmatism higher than 1 D.

Design outcomes

Primary

MeasureTime frameDescription
UDVA (Uncorrected Distance Visual Acuity)30 daysVisual acuity mesurement

Secondary

MeasureTime frameDescription
Adverse Device Effects (ADE); Serious Adverse Device Effects (SADE); Unexpected Serious Adverse Device Effects (USADE); Adverse Events (AE); Serious Adverse Events (SAE).4 monthsSafety assessment

Other

MeasureTime frameDescription
Contrast sensitivity4 monthsContrast sensitivity, at 3 meters, under photopic conditions and with the correction for distance, using YANG SMART (SIFI Medtech), with sine wave gradings (''vistech)
Halos and Glare evaluation4 monthsOnset of halos Onset of glare during night vision
Defocus Curve4 monthsBinocular defocus curves with step of 0.5 D (from +2.0 to -5.0 D) under photopic conditions.
Reading Performance4 monthsReading Performance tested with Radner Reading Chart - Precision Vision: The test will be performed from the largest to the smallest size of letters in two sessions: * Binocular, without the correction for distance, at 40 cm * Binocular, with the correction for distance, at 40 cm
Visual Acuity Evaluation4 monthsCorrected Distance Visual Acuity (CDVA)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026